Recent Finacing
Recent Raise
Cerevel develops pre-commercial CNS therapeutics, advancing clinical-stage and discovery programs across Parkinson’s, Alzheimer’s, epilepsy, schizophrenia, addiction, and neuroinflammation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Cerevel Therapeutics.
